Cancer Cells That Survive Treatment: Senescence, Dormancy, and Breast Cancer Recurrence

Why do some cancer cells survive treatment and later contribute to disease recurrence?

Your gift is doubled through December 31.

Donate Now
Date
August 28, 2026
LEAD Grads

Why do some cancer cells survive treatment and later contribute to disease recurrence?

Drs. David Gewirtz, Beverly A. Teicher, and Edward Greenberg discuss emerging research into cellular senescence and tumor dormancy—states in which cancer cells may persist following treatment without actively growing—and their potential role in treatment resistance and cancer recurrence.

NOTE: This webinar content is exclusive to Project LEAD graduates.